Tyme Technologies

Board Description

TYME is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, our therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.

Industry
Biotechnology
Country
United States
State
New Jersey
Stock Market
NASDAQ
Stock Ticker
TYME
Ranking
N/A